Explore more publications!
Iceland Health Focus
Got News to Share?

Press Releases

Alvotech announces planned CEO succession and leadership transition
January 6, 2026

Alvotech announces planned CEO succession and leadership transition

Indeterminate GlobeNewswire, Inc.
Alvotech Meets Investors and Participates in a Fireside Chat at the Morgan Stanley 23rd Annual Global Healthcare Conference in New York
September 4, 2025

Alvotech Meets Investors and Participates in a Fireside Chat at the Morgan Stanley 23rd Annual Global Healthcare Conference in New York

Indeterminate GlobeNewswire, Inc.
Resmed Launches Sleep Institute to Elevate Sleep Health as a Global Priority
September 3, 2025

Resmed Launches Sleep Institute to Elevate Sleep Health as a Global Priority

Indeterminate GlobeNewswire, Inc.
The Hidden Vegetables Cookbook Offers a New Approach to Healthy Eating Without the Stigma
September 5, 2025

The Hidden Vegetables Cookbook Offers a New Approach to Healthy Eating Without the Stigma

Indeterminate GlobeNewswire, Inc.
Oculis to Present Clinical Trial Results in Diabetic Macular Edema and Acute Optic Neuritis at Ophthalmology Conferences
September 1, 2025

Oculis to Present Clinical Trial Results in Diabetic Macular Edema and Acute Optic Neuritis at Ophthalmology Conferences

Indeterminate GlobeNewswire, Inc.
Advanz Pharma and Alvotech receive European approval for Mynzepli®, Biosimilar to Eylea®
August 21, 2025

Advanz Pharma and Alvotech receive European approval for Mynzepli®, Biosimilar to Eylea®

Indeterminate GlobeNewswire, Inc.
Oculis Appoints Mark Kupersmith, M.D., and Sebastian Wolf, M.D., Ph.D., World-Renowned Neuro-Ophthalmology and Retina Experts, as Chief Medical Advisors
August 25, 2025

Oculis Appoints Mark Kupersmith, M.D., and Sebastian Wolf, M.D., Ph.D., World-Renowned Neuro-Ophthalmology and Retina Experts, as Chief Medical Advisors

Indeterminate GlobeNewswire, Inc.
Oculis Announces U.S. FDA Breakthrough Therapy Designation Granted to Privosegtor for Treatment of Optic Neuritis
January 6, 2026

Oculis Announces U.S. FDA Breakthrough Therapy Designation Granted to Privosegtor for Treatment of Optic Neuritis

Indeterminate GlobeNewswire, Inc.
Whole Health at VA Pittsburgh
August 11, 2025

Whole Health at VA Pittsburgh

Gov't Institution U.S. Department of Veterans Affairs
Owner: American Government

U.S. Department of Veterans Affairs

Gov't Institution
Owned By American Government
Year Founded 1989
Website https://www.va.gov/
Domain Registration Year Indeterminate
Access Type open
Publication Location United States, District of Columbia, Washington
Owner Country United States

We welcome your feedback!
If you have comments or corrections, let us know.

Zevra Therapeutics Submits Marketing Authorization Application to European Medicines Agency to Review Arimoclomol for the Treatment of Niemann-Pick Disease Type C
July 28, 2025

Zevra Therapeutics Submits Marketing Authorization Application to European Medicines Agency to Review Arimoclomol for the Treatment of Niemann-Pick Disease Type C

Indeterminate GlobeNewswire, Inc.
LifeVantage To Open Iceland Market
July 24, 2025

LifeVantage To Open Iceland Market

Indeterminate GlobeNewswire, Inc.
Alvotech and Advanz Pharma Enter into European Supply and Commercialization Agreement for Biosimilar Candidate to Cimzia® (certolizumab pegol)
July 1, 2025

Alvotech and Advanz Pharma Enter into European Supply and Commercialization Agreement for Biosimilar Candidate to Cimzia® (certolizumab pegol)

Indeterminate GlobeNewswire, Inc.
Alvotech Secures Term Loan Facility of USD 100 Million
December 31, 2025

Alvotech Secures Term Loan Facility of USD 100 Million

Indeterminate GlobeNewswire, Inc.
Icelandirect Partners with Rbionutrix to Ensure Consistent Supply of High-Quality Fish Oil
April 9, 2025

Icelandirect Partners with Rbionutrix to Ensure Consistent Supply of High-Quality Fish Oil

Neutral EIN Presswire
European Medicines Agency Recommends Market Approval of AVT06, Alvotech’s Proposed Biosimilar to Eylea® (aflibercept)
June 23, 2025

European Medicines Agency Recommends Market Approval of AVT06, Alvotech’s Proposed Biosimilar to Eylea® (aflibercept)

Indeterminate GlobeNewswire, Inc.
Live Whole Health #281: Take a stand!
July 14, 2025

Live Whole Health #281: Take a stand!

Gov't Institution U.S. Department of Veterans Affairs
Owner: American Government

U.S. Department of Veterans Affairs

Gov't Institution
Owned By American Government
Year Founded 1989
Website https://www.va.gov/
Domain Registration Year Indeterminate
Access Type open
Publication Location United States, District of Columbia, Washington
Owner Country United States

We welcome your feedback!
If you have comments or corrections, let us know.

Deep-Sea Mining Market Expands as Governments and Industries Race to Secure Critical Mineral Supply Chains
January 9, 2026

Deep-Sea Mining Market Expands as Governments and Industries Race to Secure Critical Mineral Supply Chains

Indeterminate GlobeNewswire, Inc.
Alvotech Meets Investors and Presents at the Goldman Sachs Global Healthcare Conference in Miami
June 6, 2025

Alvotech Meets Investors and Presents at the Goldman Sachs Global Healthcare Conference in Miami

Indeterminate GlobeNewswire, Inc.
Alvotech Meets Investors and Presents at the Jefferies Global Healthcare Conference 2025 in New York, NY
June 2, 2025

Alvotech Meets Investors and Presents at the Jefferies Global Healthcare Conference 2025 in New York, NY

Indeterminate GlobeNewswire, Inc.
Alvotech and Advanz Pharma Extend Strategic Partnership to Commercialize Three Additional Biosimilars in Europe
May 28, 2025

Alvotech and Advanz Pharma Extend Strategic Partnership to Commercialize Three Additional Biosimilars in Europe

Indeterminate GlobeNewswire, Inc.
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions